WeTrials
Recruiting

REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

What is this study?

This study is testing a smarter way to manage blood-thinning medication for people with an irregular heartbeat called atrial fibrillation. Instead of taking blood thinners every single day, participants might use a special smartwatch to guide when they take their medication based on their heart rhythm.

Who can participate?

You may be able to join if you are between 22 and 85 years old, speak English, and have an irregular heartbeat that comes and goes. You also need to be taking a specific type of blood thinner and have a low-to-moderate stroke risk without a history of previous strokes.

What will happen?

You will be randomly assigned to either take your blood thinner continuously like normal, or use a smartwatch to guide your medication use for one month at a time. Throughout the study, you will have regular check-ins with the study team to monitor your health and heart rhythm.

Where and when?

This study is currently recruiting participants at locations in Phoenix, Arizona, and Los Angeles, California. The trial is actively looking for volunteers to help researchers learn more about safer and more flexible treatment options.

Key Points
  • 1Tests a smartwatch-guided approach to taking blood thinners
  • 2Compares smart monitoring to traditional daily medication use
  • 3Currently recruiting patients in Arizona and California

Related video

Northwestern Medicine: Dr. Rod Passman explains the REACT-AF trial (December 2024)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Atrial Fibrillation

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.